Drug-induced eczematid-like purpura of Doucas-Kapetanakis.
Tchernev G, Temelkova I.
J Biol Regul Homeost Agents. 2019 Jul-Aug;33(4):1241-1242.
Purpura.
Charrot SC, Sellar RS, Manson JJ.
Br J Hosp Med (Lond). 2017 Oct 2;78(10):C147-C151. doi: 10.12968/hmed.2017.78.10.C147.
Purpura Fulminans in an Asplenic Intravenous Drug User.
Nyers ES, Kappius RH, Winterfield LS, Elston DM.
Cutis. 2021 Nov;108(5):E9-E12. doi: 10.12788/cutis.0396.
[Drug-induced purpura].
Kikuta A, Suzuki H.
Ryoikibetsu Shokogun Shirizu. 1998;(21 Pt 2):412-5.
Immune thrombocytopenic purpura.
Psaila B, Bussel JB.
Hematol Oncol Clin North Am. 2007 Aug;21(4):743-59, vii. doi: 10.1016/j.hoc.2007.06.007.
Idiopathic thrombocytopenic purpura.
Palaniappan G, Jennings W.
Mo Med. 2009 Jan-Feb;106(1):69-73.
Purpura fulminans.
Chu DZ, Blaisdell FW.
Am J Surg. 1982 Mar;143(3):356-62. doi: 10.1016/0002-9610(82)90106-4.
Periorbital purpura following intense emesis.
Hung YT, Chen CB.
Med J Aust. 2022 May 16;216(9):454. doi: 10.5694/mja2.51504. Epub 2022 Apr 14.
Purpura fulminans due to Rickettsia japonica.
Ishii J, Haratake D, Ito M, Shime N.
QJM. 2022 Nov 14;115(11):758-759. doi: 10.1093/qjmed/hcac188.
Drug-induced purpura simplex: clinical and histological characteristics.
Pang BK, Su D, Ratnam KV.
Ann Acad Med Singap. 1993 Nov;22(6):870-2.
